Beyond The Printed Page

  1. Making A Difference Matters

    Dr. Helen Torley, president and CEO of Halozyme Therapeutics, shares a story of how the biopharmaceutical industry makes a difference.

  2. Helen Torley’s Path To The C-Suite

    Halozyme Therapeutics’ president and CEO, Dr. Helen Torley, discusses her path to the c-suite, including the formative experience that best prepared her for becoming a CEO.

  3. Could Halozyme’s U.S. Patent 8,846,034 Be Another Royalty Boon?

    Helen Torley, president and CEO of Halozyme Therapeutics, discusses hyaluronan and the role it plays in development of ENHANZE, PEGPH20 along with a staining diagnostic to determine patients with high levels of hyaluronic acid (HA).

  4. Insight For First-Time CEOs Presenting At JPM

    Halozyme Therapeutics’ president and CEO, Dr. Helen Torley, discusses her approach to preparing and presenting as a first-time CEO at the annual J.P. Morgan Healthcare Conference.

  5. Tech, Tax Cuts, Trump, & More — A Diversity Of Biopharma Perspectives For 2019

    Seven biopharmaceutical industry thought leaders weigh in on technology, tax cuts, and the political landscape to help you get ready for the coming year.

  6. 6 Biopharma Executives On Breakthroughs For 2019

    Six biopharmaceutical executives share their thoughts on therapeutic categories where they’d like to see breakthroughs in 2019 and beyond.

  7. What Can Be Done To Save Biopharma’s Broken Image?

    Rob Wright shares a personal anecdote about his experience of breaking into the biopharmaceutical industry, along with insight from three biopharma CEOs on what can be done to save the industry’s

  8. Are You Paying It Forward As A Leader?

    Liz Barrett, CEO of Novartis Oncology, discusses taking a proactive approach toward mentoring tomorrow’s leaders.

  9. Novartis Oncology CEO Liz Barrett On Balancing Career And Family

    Novartis Oncology CEO, Liz Barrett, on career advancement and family, a common challenge for women in the workplace.

  10. Challenges Of Transformation And Balancing An Internal And External Network From BMS’s Lou Schmukler

    Lou Schmukler, president of global product development and supply at Bristol-Myers Squibb, provides a preview as to his approach to transformation the company’s product development and manufacturing operations, along with insight into the world of biopharmaceutical outsourcing.